Literature DB >> 28164765

Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview.

Khurshid Ahmad1, Mohammad Hassan Baig2, Gohar Mushtaq3, Mohammad Amjad Kamal4, Nigel H Greig5, Inho Choi2.   

Abstract

BACKGROUND: Alzheimer's disease (AD) is the most common and well-studied neurodegenerative disease (ND). Biological pathways, pathophysiology and genetics of AD show commonalities with other NDs viz. Parkinson's disease (PD), Amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), Prion disease and Dentatorubral-pallidoluysian atrophy (DRPLA). Many of the NDs, sharing the common features and molecular mechanisms suggest that pathology may be directly comparable and be implicated in disease prevention and development of highly effective therapies.
METHOD: In this review, a brief description of pathophysiology, clinical symptoms and available treatment of various NDs have been explored with special emphasis on AD. Commonalities in these fatal NDs provide support for therapeutic advancements and enhance the understanding of disease manifestation.
CONCLUSION: The studies concentrating on the commonalities in biological pathways, cellular mechanisms and genetics may provide the scope to researchers to identify few novel common target(s) for disease prevention and development of effective common drugs for multi-neurodegenerative diseases. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alzheimer disease; Amyotrophic lateralzzm321990sclerosis; Huntington's disease; Neurodegenerative diseases; Parkinson's disease; biological pathways

Mesh:

Year:  2017        PMID: 28164765      PMCID: PMC5878041          DOI: 10.2174/1567205014666170203141151

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  73 in total

Review 1.  Protein misfolding and disease; protein refolding and therapy.

Authors:  C Soto
Journal:  FEBS Lett       Date:  2001-06-08       Impact factor: 4.124

Review 2.  Neurodegeneration: what is it and where are we?

Authors:  Serge Przedborski; Miquel Vila; Vernice Jackson-Lewis
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

3.  Genetics in the age of systems biology.

Authors:  Peter Robin Hiesinger; Bassem A Hassan
Journal:  Cell       Date:  2005-12-29       Impact factor: 41.582

Review 4.  Amyotrophic lateral sclerosis as a complex genetic disease.

Authors:  Claire L Simpson; Ammar Al-Chalabi
Journal:  Biochim Biophys Acta       Date:  2006-08-05

5.  The human disease network.

Authors:  Kwang-Il Goh; Michael E Cusick; David Valle; Barton Childs; Marc Vidal; Albert-László Barabási
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-14       Impact factor: 11.205

6.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.

Authors:  M C Chartier-Harlin; F Crawford; H Houlden; A Warren; D Hughes; L Fidani; A Goate; M Rossor; P Roques; J Hardy
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

Review 7.  Promise of pharmacogenomics for drug discovery, treatment and prevention of Parkinson's disease. A perspective.

Authors:  Haydeh Payami; Stewart A Factor
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

8.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

Authors:  D Games; D Adams; R Alessandrini; R Barbour; P Berthelette; C Blackwell; T Carr; J Clemens; T Donaldson; F Gillespie
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

9.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

Review 10.  Protein-protein interaction detection: methods and analysis.

Authors:  V Srinivasa Rao; K Srinivas; G N Sujini; G N Sunand Kumar
Journal:  Int J Proteomics       Date:  2014-02-17
View more
  12 in total

1.  Clustering of Alzheimer's and Parkinson's disease based on genetic burden of shared molecular mechanisms.

Authors:  Mohammad Asif Emon; Ashley Heinson; Ping Wu; Daniel Domingo-Fernández; Meemansa Sood; Henri Vrooman; Jean-Christophe Corvol; Phil Scordis; Martin Hofmann-Apitius; Holger Fröhlich
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

2.  Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease.

Authors:  Zhiwu Dong; Hongjun Gu; Qiang Guo; Shuang Liang; Jian Xue; Feng Yao; Xianglu Liu; Feifei Li; Huiling Liu; Li Sun; Kewen Zhao
Journal:  Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.590

3.  Questioning Glutamate Excitotoxicity in Acute Brain Damage: The Importance of Spreading Depolarization.

Authors:  R David Andrew; Eszter Farkas; Jed A Hartings; K C Brennan; Oscar Herreras; Michael Müller; Sergei A Kirov; Cenk Ayata; Nikita Ollen-Bittle; Clemens Reiffurth; Omer Revah; R Meldrum Robertson; Ken D Dawson-Scully; Ghanim Ullah; Jens P Dreier
Journal:  Neurocrit Care       Date:  2022-02-22       Impact factor: 3.532

4.  Bar-coding neurodegeneration: identifying subcellular effects of human neurodegenerative disease proteins using Drosophila leg neurons.

Authors:  Josefin Fernius; Annika Starkenberg; Stefan Thor
Journal:  Dis Model Mech       Date:  2017-06-14       Impact factor: 5.758

Review 5.  Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious Update.

Authors:  Arif Tasleem Jan; Mudsser Azam; Safikur Rahman; Angham M S Almigeiti; Duk Hwan Choi; Eun Ju Lee; Qazi Mohd Rizwanul Haq; Inho Choi
Journal:  Front Aging Neurosci       Date:  2017-11-01       Impact factor: 5.750

6.  Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis.

Authors:  Elisa Longinetti; Daniela Mariosa; Henrik Larsson; Weimin Ye; Caroline Ingre; Catarina Almqvist; Paul Lichtenstein; Fredrik Piehl; Fang Fang
Journal:  Neurology       Date:  2017-07-12       Impact factor: 9.910

7.  Pretreatment Effect of Inflammatory Stimuli and Characteristics of Tryptophan Transport on Brain Capillary Endothelial (TR-BBB) and Motor Neuron Like (NSC-34) Cell Lines.

Authors:  Asmita Gyawali; Young-Sook Kang
Journal:  Biomedicines       Date:  2020-12-24

8.  Edaravone Exerts Brain Protective Function by Reducing the Expression of AQP4, APP and Aβ Proteins.

Authors:  Haiyan Ren; Lijuan Ma; Xueli Gong; Chenbo Xu; Yuge Zhang; Meilei Ma; Kenichi Watanabe; Juan Wen
Journal:  Open Life Sci       Date:  2019-12-31       Impact factor: 0.938

Review 9.  A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.

Authors:  Dong Seok Kim; Ho-Il Choi; Yun Wang; Yu Luo; Barry J Hoffer; Nigel H Greig
Journal:  Cell Transplant       Date:  2017-09       Impact factor: 4.064

10.  Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines.

Authors:  Masaru Tanaka; József Toldi; László Vécsei
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.